Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms

Background. Platinum-based chemotherapy is the mainstay of front-line treatment of patients affected by pluri-metastatic intermediate/high grade NeuroEndocrine Neoplasms (NENs). However, there are no standard second-line treatments at disease progression. Previous clinical experiences have evidenced...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Clin Med
Huvudupphovsmän: Tafuto, Salvatore, von Arx, Claudia, Capozzi, Monica, Tatangelo, Fabiana, Mura, Manuela, Modica, Roberta, Barretta, Maria Luisa, Di Sarno, Antonella, Tornesello, Maria Lina, Colao, Annamaria, Ottaiano, Alessandro
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6723560/
https://ncbi.nlm.nih.gov/pubmed/31443197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8081224
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk